The first batch of Chinese#vaccine aid, developed by Sinopharm's subsidiary China National Biotec Group, arrived in Islamabad on Monday. #Pakistan 's FM Shah Mahmood Qureshi said the vaccines will be given to the country's medics first at the delivery ceremony.
Coronavirus: China National Biotec Group vouches for its vaccine against mutant strains spreading overseas
Development of Chinese #COVID19 vaccine revealed in a documentary. Inactivated COVID-19 vaccine of China National Biotec Group began to be researched in the P4 and P3 laboratory in #Wuhan , which has the highest level of bio-safety protection in #China
Vice president of China National Biotec Group Company (CNBG) said the company is supplementing data of vaccines on people between ages of 3 and 17 in the hope of expanding the population range eligible for inoculation.
A Chinese inactivated vaccine shows 79.34% efficacy against #COVID19 , according to the interim results of the phase-3 clinical trials unveiled by the China National Biotec Group #CNBG ) on Wednesday.
China National Biotec Group said Sat that the production capacity of its #COVID19 vaccine is expected to reach 1 bln doses in 2021. The current workshops in Beijing and Wuhan have an annual output of 300 mln. The construction of more workshops will be completed by the year-end.
State-backed vaccine maker China National Biotec Group is hopeful of two of its coronavirus vaccine candidates receiving conditional regulatory approval for general public use within the year, its vice president said
Four more countries have agreed to run late-stage clinical tests of coronavirus vaccine candidates from China National Biotec Group and Sinovac Biotech as China steps up its efforts in the global race
China National Biotec Group and Sinovac Biotech said four more countries have agreed to run late-stage clinical tests of their coronavirus vaccine candidates
32 recovered #COVID19 patients have donated 10,650 ml of plasma by Sat, said China National Biotec Group, a state-owned biological products maker. The company announced on Fri that it has developed convalescent plasma to treat patients with novel coronavirus pneumonia.